[1]
Wijdan Abdullameer Kamel 2026. Biochemical and Clinical Evaluation of Novel Tyrosine Kinase Inhibitors in Breast Cancer: Molecular Docking and Biomarker Correlation Study. International Journal of Scientific Research and Innovative Studies. 5, 2 (Apr. 2026), 252–265. DOI:https://doi.org/10.63883/ijsrisjournal.v5i2.653.